As of 2026-04-02, the Relative Valuation of Dyne Therapeutics Inc (DYN) is (55.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.10 USD, the upside of Dyne Therapeutics Inc based on Relative Valuation is -409.2%.
The range of the Relative Valuation is (51.70) - (58.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.0x | 20.5x |
| Forward P/E multiples | 18.3x - 21.7x | 20.9x |
| Fair Price | (51.70) - (58.62) | (55.97) |
| Upside | -385.6% - -423.9% | -409.2% |
| Date | P/E |
| 2026-04-01 | -6.69 |
| 2026-03-31 | -6.71 |
| 2026-03-30 | -6.32 |
| 2026-03-27 | -6.34 |
| 2026-03-26 | -6.86 |
| 2026-03-25 | -7.02 |
| 2026-03-24 | -6.60 |
| 2026-03-23 | -6.61 |
| 2026-03-20 | -6.49 |
| 2026-03-19 | -6.58 |
| 2026-03-18 | -6.76 |
| 2026-03-17 | -6.90 |
| 2026-03-16 | -6.71 |
| 2026-03-13 | -6.63 |
| 2026-03-12 | -6.68 |
| 2026-03-11 | -7.39 |
| 2026-03-10 | -7.32 |
| 2026-03-09 | -6.54 |
| 2026-03-06 | -5.50 |
| 2026-03-05 | -5.62 |
| 2026-03-04 | -5.63 |
| 2026-03-03 | -5.40 |
| 2026-03-02 | -5.97 |
| 2026-02-27 | -5.78 |
| 2026-02-26 | -5.99 |
| 2026-02-25 | -5.95 |
| 2026-02-24 | -5.75 |
| 2026-02-23 | -5.71 |
| 2026-02-20 | -5.50 |
| 2026-02-19 | -5.64 |
| 2026-02-18 | -5.69 |
| 2026-02-17 | -5.65 |
| 2026-02-13 | -5.75 |
| 2026-02-12 | -5.92 |
| 2026-02-11 | -6.17 |
| 2026-02-10 | -6.34 |
| 2026-02-09 | -6.28 |
| 2026-02-06 | -6.21 |
| 2026-02-05 | -6.12 |
| 2026-02-04 | -6.74 |
| 2026-02-03 | -7.01 |
| 2026-02-02 | -6.94 |
| 2026-01-30 | -6.62 |
| 2026-01-29 | -6.61 |
| 2026-01-28 | -6.55 |
| 2026-01-27 | -6.67 |
| 2026-01-26 | -6.66 |
| 2026-01-23 | -6.66 |
| 2026-01-22 | -6.69 |
| 2026-01-21 | -6.47 |